Nosocomial transmission of CTX-M-2 β-lactamase-producing Acinetobacter baumannii in a neurosurgery ward

Journal of Clinical Microbiology

Volumn 42, Issue 9, 2004, Pages 3978-3984

  Nagano, Noriyuki ^a,d   Nagano, Yukiko ^a   Cordevant, Christophe ^c   Shibata, Naohiro ^b   Arakawa, Yoshichika ^b  

^a Funabashi Municipal Medical Center   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c INSTITUT PASTEUR DE LILLE   (France)

^d Funabashi Municipal Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAMASE; CEFACLOR; CEFAZOLIN; CEFEPIME; CEFMETAZOLE; CEFOTETAN; CEFOXITIN; CEFOZOPRAN; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; FLOMOXEF; FOSFOMYCIN; GENTAMICIN; HABEKACIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; PIPERACILLIN; SULPERAZON; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; NEUROSURGERY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; WARD;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BASE SEQUENCE; CEFOTAXIME; CROSS INFECTION; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

ACINETOBACTER; ACINETOBACTER BAUMANNII; MIRABILIS; NEGIBACTERIA; PROTEUS MIRABILIS;

EID: 4644315827     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.9.3978-3984.2004     Document Type: Article

References (57)

1. Afzal-Shah, M., and D. M. Livermore. 1998. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J. Antimicrob. Chemother. 41:576-577.
2. Ayan, M., R. Durmaz, E. Aktas, and B. Durmaz. 2003. Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital. J. Hosp. Infect. 54:39-45.
3. Bauernfeind, A., I. Stemplinger, R. Jungwirth, S. Ernst, and J. M. Casellas. 1996. Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases. Antimicrob. Agents Chemother. 40:509-513.
4. Bergogne-Berezin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
5. Bonnet, R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
6. Bou, G., G. Cerveró, M. A. Domínguez, C. Quereda, and J. Martínez-Beltrán. 2000. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A baumannii is not due solely to the presence of ́-lactamases. J. Clin. Microbiol. 38:3299-3305.
7. Bou, G., and J. Martínez-Beltrán. 2000. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC ́-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44:428-432.
8. Bradford, P. A. 2001. Extended-spectrum ́-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
9. Bradford, P. A., C. E. Cherubin, V. Idemyor, B. A. Rasmussen, and K. Bush. 1994. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing ́-lactamases in a single isolate. Antimicrob. Agents Chemother. 38:761-766.
10. Bradford, P. A., C. Urban, A. Jaiswal, N. Mariano, B. A. Rasmussen, S. J. Projan, J. J. Rahal, and K. Bush. 1995. SHV-7, a novel cefotaxime-hydrolyzing ́-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob. Agents Chemother. 39:899-905.
11. Brisse, S., D. Milatovic, A. C. Fluit, K. Kusters, A. Toelstra, J. Verhoef, and F. Schmitz. 2000. Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping. J. Clin. Microbiol. 38:3636-3645.
12. Corbella, X., A. Montero, M. Pujol, M. A. Domínguez, J. Ayats, M. J. Argerich, F. Garrigosa, J. Ariza, and F. Gudiol. 2000. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J. Clin. Microbiol. 38:4086-4095.
13. Cordevant, C., J. S. Tang, D. Cleland, and M. Lange. 2003. Characterization of members of the Legionellaceae family by automated ribotyping. J. Clin. Microbiol. 41:34-43.
14. Da Silva, G. J., G. J. Leitao, and L. Peixe. 1999. Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates. J. Clin. Microbiol. 37:2109-2110.
15. de Vries. J., and W. Wackernagel. 2002. Integration of foreign DNA during natural transformation of Acinetobacter sp. by homology-facilitated illegitimate recombination. Proc. Natl. Acad. Sci. USA 99:2094-2099.
16. Dice, L. R. 1945. Measures of the amount of ecological associations between species. J. Ecol. 26:297-302.
17. Dijkshoorn, L., H. Aucken, P. Gerner-Smidt, P. Janssen, M. E. Kaufmann, J. Garaizar, J. Ursing, and T. L. Pitt. 1996. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J. Clin. Microbiol. 34:1519-1525.
18. Doi, Y., N. Shibata, K. Shibayama, K. Kamachi, H. Knrokawa, K. Yokohama, T. Yagi, and Y. Arakawa. 2002. Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 46:2427-2434.
19. Donald, H. M., W. Scaife, S. G. B. Amyes, and H. K. Young. 2000. Sequence analysis of ARI-1, a novel OXA β-lactamase responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob. Agents Chemother. 44:196-199.
20. Fernández-Cuenca, F., L. Martínez-Martínez, M. C. Conejo, J. A. Ayala, E. J. Perea, and A. Pascual. 2003. Relationship between ́-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 51:565-574.
21. Fierobe, L., J. C. Lucet, D. Decre, C. Muller-Serieys, A. Deleuze, M. L. Joly-Guillou, J. Mantz, and J. M. Desmonts. 2001. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients. Infect. Control Hosp. Epidemiol. 22:35-40.
22. Forster, D. H., and F. D. Daschner. 1998. Acinetobacter species as nosocomial pathogens. Eur. J. Clin. Microbiol. Infect. 17:73-77.
23. Go, E. S., C. Urban, J. Burns, B. Kreiswirth, W. Eisner, N. Mariano, K. Mosinka-Snipas, and J. J. Rahal. 1994. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344:1329-1332.
24. Ishii, Y., A. Ohno, H. Taguchi, S. Imajo, M. Ishiguro, and H. Matsuzawa. 1995. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli. Antimicrob. Agents Chemother. 39:2269-2275.
25. Komatsu, M., N. Ikeda, M. Aihara, V. Nakamachi, S. Kinoshita, K. Yamasaki, and K. Shimakawa. 2001. Hospital outbreak of MEN-1-derived extended spectrum β-lactamase-producing Klebsiella pneumoniae. J. Infect. Chemother. 7:94-101.
26. Kwon, N. Y., J. D. Kim, and H. J. Pai. 2002. The resistance mechanism of β-lactam antimicrobials in clinical isolates of Acinetobacter baumannii. Korean J. Intern. Med. 17:94-99.
27. Limansky, A. S., M. A. Mussi, and A. M. Viale. 2002. Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J. Clin. Microbiol. 40:4776-4778.
28. Lindquist, S., M. Galleni, F. Lindberg, and S. Normark. 1989. Signalling proteins in enterobacterial AmpC β-lactamase regulation. Mol. Microbiol. 3:1091-1102.
29. Ling, M. L., A. Ang, M. Wee, and G. C. Wang. 2001. A nosocomial outbreak of multiresistant Acinetobacter baumannii originating from an intensive care unit. Infect. Control Hosp. Epidemiol. 22:48-49.
30. Livermore, D. M., and D. F. J. Brown. 2001. Detection of β-lactamase-mediated resistance. J. Antimicrob. Chemother. 48(Suppl. S1):59-64.
31. Lyytikäinen, O., S. Köljalg, M. Härmä, and J. Vuopio-Varvika. 1995. Outbreak caused by two multaesistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem. J. Hosp. Infect. 31:41-54.
32. Ma, L., Y. Ishii, M. Ishiguro, H. Matsuzawa, and K. Yamaguchi. 1998. Cloning and sequencing of the gene encoding Toho-2, a class A β-lactamase preferentially inhibited by tazobactam. Antimicrob. Agents Chemother. 42: 1181-1180.
33. Nagano, N., J. Sato, C. Cordevant, Y. Nagano, F. Taguchi, and M. Inoue. 2003. Presumed endocarditis caused by BRO β-lactamase-producing Moraxella lacunata in an infant with Fallot's tetrad. J. Clin. Microbiol. 41:5310-5312.
34. Nagano, N., N. Shibata, Y. Saitou, Y. Nagano, and Y. Arakawa. 2003. Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type β-lactamase. J. Clin. Microbiol. 41:5530-5536.
35. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Approved standard M100-S12. National Committee for Clinical Laboratory Standards, Wayne, Pa.
36. Nielsen, K. M., M. D. van Weerelt, T. N. Berg, A. M. Bones, A. N. Hagler, and J. D. van Elsas. 1997. Natural transformation and availability of transforming DNA to Acinetobacter calcoaceticus in soil microcosms. Appl. Environ. Microbiol. 63:1945-1952.
37. Okamoto, R., and M. Inoue. 1995. P/Case test for β-lactamase detection. Media Circle 40:173-180. (In Japanese.)
38. Pagani, L., E. Dell'Amico, R. Migliavacca, M. M. D'Andrea, E. Giacobone, G. Amicosante, E. Romero, and G. M. Rossolini. 2003. Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J. Clin. Microbiol. 41:4264-4269.
39. Paton, R., R. S. Miles, J. Hood, and S. G. B. Amyes. 1993. ARI-1: β-lactamase mediated imipenem resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 2:81-88.
40. Poirel, L., A. Karim, A. Mercat, I. Le Thomas, H. Vahaboglu, C. Richard, and P. Nordmann. 1999. Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J. Antimicrob. Chemother. 43:157-165.
41. Poirel, L., O. Menuteau, N. Agoli, C. Cattoen, and P. Nordmann. 2003. Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol. 41:3542-3547.
42. Prinarakis, E. E., E. Tzelepi, M. Gazouli, A. F. Mentis, and L. S. Tzouvelekis. 1996. Characterization of a novel SHV β-lactamase variant that resembles the SHV-5 enzyme. FEMS Microbiol. Lett. 139:229-234.
43. Radice, M., C. Gonzealez, P. Power, M. C. Vidal, and G. Gutkind. 2001. Third-generation cephalosporin resistance in Shigella sonnei, Argentina. Emerg. Infect. Dis. 7:442-443.
44. Raimondi, A., F. Sisto, and H. Nikaido. 2001. Mutation in Serratia marcescens AmpC β-lactamase producing high-level resistance to ceftazidime and cefpirome. Antimicrob. Agents Chemother. 45:2331-2339.
45. 1MP allelic variants carried by gene cassettes of different phylogeny. Antimicrob. Agents Chemother. 44:1229-1235.
46. Sasaki, T., T. Nishiyama, M. Shintani, and T. Kenri. 1997. Evaluation of a new method for identification of bacteria based on sequence homology of 16S rRNA gene. PDA J. Pharm. Sci. Technol. 51:242-247.
47. Shiraki, Y., N. Shibata, Y. Doi, and Y Arakawa. 2004. Escherichia coll producing CTX-M-2 β-lactamase in cattle, Japan. Emerg. Infect. Dis. 10: 69-75.
48. Sirot, J. 1996. Detection of extended-spectrum plasmid-mediated β-lactamases by disk diffusion. Clin. Microbiol. Infect. 2:S35-S39.
49. Sneath, P. H. A., and R. R. Sokal. 1973. Numerical taxonomy. W. H. Freeman & Company, San Francisco, Calif.
50. Sutdiffe, J. G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75:3737-3741.
51. Takahashi, A., S. Yomoda, I. Kobayashi, T. Okubo, M. Tsunoda. and S. Iyobe. 2000. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. J. Clin. Microbiol. 38:526-529.
52. Vahaboglu, H., R. Öztürk, G. Aygün, F. Coskunkan, A. Yaman, A. Kaygusuz, H. Leblebicioglu, I. Balik, K. Aydin, and M. Otkun. 1997. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob. Agents Chemother. 41:2265-2269.
53. Vila, J., M. Navia, J. Ruiz, and C. Casals. 1997. Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 41:2757-2759.
54. Wang, S. H., W. H. Sheng, Y. Y. Chang, L. H. Wang, H. C. Lin, M. L. Chen, H. J. Pan, W. J. Ko, S. C. Chang, and F. Y. Lin. 2003. Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J. Hosp. Infect. 53:97-102.
55. Yagi, T., H. Kurokawa, N. Shibata, K. Shihayama, K. Shimokata, and Y. Arakawa. 2000. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol. Lett. 184:53-56.
56. Yang, Y., N. Bhachech, P. A. Bradford, B. D. Jett, D. F. Sahm, and K. Bush. 1998. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 from St. Louis. Antimicrob. Agents Chemother. 42:1671-1676.
57. VIM-2 gene cassettes. J. Antimicrob. Chemother. 49:837-840.